Literature DB >> 31900342

Type II but Not Type I IFN Signaling Is Indispensable for TLR7-Promoted Development of Autoreactive B Cells and Systemic Autoimmunity.

Sathi Babu Chodisetti1, Adam J Fike1, Phillip P Domeier1, Harinder Singh2, Nicholas M Choi1, Chelsea Corradetti3, Yuka Imamura Kawasawa4,5, Timothy K Cooper6, Roberto Caricchio3, Ziaur S M Rahman7.   

Abstract

TLR7 is associated with development of systemic lupus erythematosus (SLE), but the underlying mechanisms are incompletely understood. Although TLRs are known to activate type I IFN (T1IFN) signaling, the role of T1IFN and IFN-γ signaling in differential regulation of TLR7-mediated Ab-forming cell (AFC) and germinal center (GC) responses, and SLE development has never been directly investigated. Using TLR7-induced and TLR7 overexpression models of SLE, we report in this study a previously unrecognized indispensable role of TLR7-induced IFN-γ signaling in promoting AFC and GC responses, leading to autoreactive B cell and SLE development. T1IFN signaling in contrast, only modestly contributed to autoimmune responses and the disease process in these mice. TLR7 ligand imiquimod treated IFN-γ reporter mice show that CD4+ effector T cells including follicular helper T (Tfh) cells are the major producers of TLR7-induced IFN-γ. Transcriptomic analysis of splenic tissues from imiquimod-treated autoimmune-prone B6.Sle1b mice sufficient and deficient for IFN-γR indicates that TLR7-induced IFN-γ activates multiple signaling pathways to regulate TLR7-promoted SLE. Conditional deletion of Ifngr1 gene in peripheral B cells further demonstrates that TLR7-driven autoimmune AFC, GC and Tfh responses and SLE development are dependent on IFN-γ signaling in B cells. Finally, we show crucial B cell-intrinsic roles of STAT1 and T-bet in TLR7-driven GC, Tfh and plasma cell differentiation. Altogether, we uncover a nonredundant role for IFN-γ and its downstream signaling molecules STAT1 and T-bet in B cells in promoting TLR7-driven AFC, GC, and SLE development whereas T1IFN signaling moderately contributes to these processes.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31900342      PMCID: PMC7002260          DOI: 10.4049/jimmunol.1901175

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  76 in total

1.  Plasma cell differentiation requires the transcription factor XBP-1.

Authors:  A M Reimold; N N Iwakoshi; J Manis; P Vallabhajosyula; E Szomolanyi-Tsuda; E M Gravallese; D Friend; M J Grusby; F Alt; L H Glimcher
Journal:  Nature       Date:  2001-07-19       Impact factor: 49.962

2.  Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc.

Authors:  B R Lawson; G J Prud'homme; Y Chang; H A Gardner; J Kuan; D H Kono; A N Theofilopoulos
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

3.  Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation.

Authors:  Shaun W Jackson; Nicole E Scharping; Nikita S Kolhatkar; Socheath Khim; Marc A Schwartz; Quan-Zhen Li; Kelly L Hudkins; Charles E Alpers; Denny Liggitt; David J Rawlings
Journal:  J Immunol       Date:  2014-04-07       Impact factor: 5.422

4.  STAT1 interacts directly with cyclin D1/Cdk4 and mediates cell cycle arrest.

Authors:  Gloria Dimco; Richard A Knight; David S Latchman; Anastasis Stephanou
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

5.  Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus.

Authors:  Lino L Teichmann; Dominik Schenten; Ruslan Medzhitov; Michael Kashgarian; Mark J Shlomchik
Journal:  Immunity       Date:  2013-03-14       Impact factor: 31.745

Review 6.  Dysregulation of germinal centres in autoimmune disease.

Authors:  Carola G Vinuesa; Iñaki Sanz; Matthew C Cook
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

7.  TLR7 escapes X chromosome inactivation in immune cells.

Authors:  Mélanie Souyris; Claire Cenac; Pascal Azar; Danièle Daviaud; Astrid Canivet; Solange Grunenwald; Catherine Pienkowski; Julie Chaumeil; José E Mejía; Jean-Charles Guéry
Journal:  Sci Immunol       Date:  2018-01-26

Review 8.  Chemokines and Chemokine Receptors in the Development of Lupus Nephritis.

Authors:  Xiaofeng Liao; Tharshikha Pirapakaran; Xin M Luo
Journal:  Mediators Inflamm       Date:  2016-06-14       Impact factor: 4.711

Review 9.  Age-Associated B Cells: A T-bet-Dependent Effector with Roles in Protective and Pathogenic Immunity.

Authors:  Kira Rubtsova; Anatoly V Rubtsov; Michael P Cancro; Philippa Marrack
Journal:  J Immunol       Date:  2015-09-01       Impact factor: 5.422

10.  B-Cell-Intrinsic Type 1 Interferon Signaling Is Crucial for Loss of Tolerance and the Development of Autoreactive B Cells.

Authors:  Phillip P Domeier; Sathi Babu Chodisetti; Stephanie L Schell; Yuka Imamura Kawasawa; Melinda J Fasnacht; Chetna Soni; Ziaur S M Rahman
Journal:  Cell Rep       Date:  2018-07-10       Impact factor: 9.423

View more
  20 in total

1.  Silencing of TLR7 protects against lipopolysaccharide-induced chondrocyte apoptosis and injury by blocking the p21-mediated JAK2/STAT3 pathway.

Authors:  Dan Liu; Wei Liu; Limin Jiang; Shengjie Dong; Weihua Ma; Shijun Wang; Chao Wan
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

Review 2.  TLR7 Signaling in Lupus B Cells: New Insights into Synergizing Factors and Downstream Signals.

Authors:  Anne B Satterthwaite
Journal:  Curr Rheumatol Rep       Date:  2021-11-24       Impact factor: 4.592

3.  Effectiveness and safety of allergen immunotherapy in patients with allergic rhinitis complicated by rheumatic autoimmune diseases: a case series study.

Authors:  Kazuki Fujioka; Akiko Kasahara; Takashi Kida; Wataru Fujii; Takahiro Seno; Makoto Wada; Masataka Kohno; Yutaka Kawahito
Journal:  Allergy Asthma Clin Immunol       Date:  2022-07-11       Impact factor: 3.373

4.  Context-Dependent miR-21 Regulation of TLR7-Mediated Autoimmune and Foreign Antigen-Driven Antibody-Forming Cell and Germinal Center Responses.

Authors:  Stephanie L Schell; Kristen N Bricker; Adam J Fike; Sathi Babu Chodisetti; Phillip P Domeier; Nicholas M Choi; Melinda J Fasnacht; Sara A Luckenbill; Steven F Ziegler; Ziaur S M Rahman
Journal:  J Immunol       Date:  2021-05-26       Impact factor: 5.422

Review 5.  Bite of the wolf: innate immune responses propagate autoimmunity in lupus.

Authors:  Sarthak Gupta; Mariana J Kaplan
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

6.  Variety of endosomal TLRs and Interferons (IFN-α, IFN-β, IFN-γ) expression profiles in patients with SLE, SSc and MCTD.

Authors:  A Paradowska-Gorycka; A Wajda; B Stypinska; E Walczuk; E Rzeszotarska; M Walczyk; E Haladyj; K Romanowska-Prochnicka; A Felis-Giemza; A Lewandowska; M Olesińska
Journal:  Clin Exp Immunol       Date:  2021-01-17       Impact factor: 5.732

7.  Serine Phosphorylation of the STAT1 Transactivation Domain Promotes Autoreactive B Cell and Systemic Autoimmunity Development.

Authors:  Sathi Babu Chodisetti; Adam J Fike; Phillip P Domeier; Stephanie L Schell; Taryn E Mockus; Nicholas M Choi; Chelsea Corradetti; Baidong Hou; Hannah M Atkins; Roberto Caricchio; Thomas Decker; Aron E Lukacher; Nancy Olsen; Ziaur S M Rahman
Journal:  J Immunol       Date:  2020-04-06       Impact factor: 5.426

Review 8.  Abnormalities of the type I interferon signaling pathway in lupus autoimmunity.

Authors:  Stefania Gallucci; Sowmya Meka; Ana M Gamero
Journal:  Cytokine       Date:  2021-07-30       Impact factor: 3.926

9.  TLR7 Negatively Regulates B10 Cells Predominantly in an IFNγ Signaling Dependent Manner.

Authors:  Sathi Babu Chodisetti; Adam J Fike; Phillip P Domeier; Nicholas M Choi; Chetna Soni; Ziaur S M Rahman
Journal:  Front Immunol       Date:  2020-07-28       Impact factor: 7.561

10.  IFN-γ Mediates the Development of Systemic Lupus Erythematosus.

Authors:  Wenping Liu; Mengdi Li; Ziye Wang; Jibo Wang
Journal:  Biomed Res Int       Date:  2020-10-17       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.